Intraperitoneal and intracranial experimental cysticercosis present different metabolic preferences after treatment with isolated or combined albendazole and nitazoxanide

dc.creatorPicanço, Guaraciara de Andrade
dc.creatorLima, Nayana Ferreira de
dc.creatorGomes, Taynara Cristina
dc.creatorAlves, Daniella de Sousa Mendes Moreira
dc.creatorCosta, Tatiane Luiza da
dc.creatorVinaud, Marina Clare
dc.date.accessioned2025-02-27T15:15:06Z
dc.date.available2025-02-27T15:15:06Z
dc.date.issued2022
dc.description.abstractCysticercosis is a zoonotic public health issue especially severe when the parasite is in the central nervous system although it may be found all over the human organism. Taenia crassiceps cysticerci inoculated in mice is the experimental model used to study cysticercosis. The most used cysticercosis treatment is with albendazole (ABZ). Nitazoxanide (NTZ) has been experimentally tested against this parasite. Metabolic analysis has been used to determine drugs impact on the parasite. The aim of this study was to determine the in vivo metabolic impact of the ABZ-NTZ combination in T. crassiceps cysticerci inoculated in mice peritoneal and intracranial cavities. Mice were experimentally inoculated with T. crassiceps cysticerci in the intraperitoneal cavity or in the intracranial one. Thirty days after the infection they were treated with NaCl 0.9% (control group), 50 mg/kg of ABZ, 50 mg/ kg of NTZ or 50 mg/kg of NTZ and ABZ (ABZ/NTZ combination). 24 h after treatment the animals were euthanized and the cysticerci analyzed through high performance chromatography and spectrophotometry in order to detect the glycolytic, mitochondrial and protein catabolism pathways. The intracranial parasites used more intensely the homolactic fermentation while the intraperitoneal ones presented a greater use of the mitochondrial pathways and protein catabolism. Regarding the glycolytic pathways, it was possible to observe a significant impact induced by the drugs used, both isolated or in combination. It was possible to detect an in crease in the fumarate reductase pathway after the drugs exposure and no impact in the protein’s catabolism. Therefore, the cysticerci showed different uses of metabolic pathways regarding the site of inoculation due to the availability of nutrients inherent of each environment. This study showed the parasite metabolic resilience and capability of use of different biochemical pathways in order to ensure survival in spite of a hostile environment.
dc.identifier.citationPICANÇO, Guaraciara de Andrade et al. Intraperitoneal and intracranial experimental cysticercosis present different metabolic preferences after treatment with isolated or combined albendazole and nitazoxanide. Acta Trópica, Amsterdam, v. 226, e106264, 2022. DOI: 10.1016/j.actatropica.2021.106264. Disponível em: https://www.sciencedirect.com/science/article/pii/S0001706X21004423. Acesso em: 20 fev. 2025.
dc.identifier.doi10.1016/j.actatropica.2021.106264
dc.identifier.issn0001-706X
dc.identifier.issne- 1873-6254
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0001706X21004423
dc.language.isoeng
dc.publisher.countryHolanda
dc.publisher.departmentInstituto de Patologia Tropical e Saúde Pública - IPTSP (RMG)
dc.rightsAcesso Restrito
dc.subjectExperimental cysticercosis
dc.subjectTaenia crassiceps
dc.subjectMetabolism
dc.subjectAlbendazole
dc.subjectNitazoxanide
dc.titleIntraperitoneal and intracranial experimental cysticercosis present different metabolic preferences after treatment with isolated or combined albendazole and nitazoxanide
dc.typeArtigo

Arquivos

Licença do Pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: